Skip to main content
. 2022 Jan 27;8(3):20210222. doi: 10.1259/bjrcr.20210222

Figure 2.

Figure 2.

A. Gallium68-DOTATATE PET/CT MIP image shows numerous tracer avid lesions involving the skeleton, lymph nodes and liver, compatible with somatostatin receptor positive lesions. (B, C) The residual left skull base lesion demonstrates intense tracer uptake with SUVmax 29.0. MIP: Maximal Intensity Projection. SUV: Standard Uptake Value.